- Home
- LGVN vs SBFM Comparison
LGVN vs SBFM Comparison
Compare LGVN & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LGVN | SBFM |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.4M | 4.3M |
| IPO Year | 2021 | 2008 |
Fundamental Metrics
Financial Performance| Metric | LGVN | SBFM |
|---|---|---|
| Price | $7.33 | $1.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.00 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 426.9K | 388.2K |
| Earning Date | 05-08-2026 | 04-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.76 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $709,000.00 | ★ $36,305,891.00 |
| Revenue This Year | N/A | $40.47 |
| Revenue Next Year | $10.81 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 4.11 |
| 52 Week Low | $0.48 | $0.25 |
| 52 Week High | $7.30 | $3.05 |
Technical Indicators
Market Signals| Indicator | LGVN | SBFM |
|---|---|---|
| Relative Strength Index (RSI) | 85.61 | 36.73 |
| Support Level | $0.61 | $0.27 |
| Resistance Level | $7.30 | $1.29 |
| Average True Range (ATR) | 0.34 | 0.09 |
| MACD | 0.26 | 0.01 |
| Stochastic Oscillator | 89.49 | 23.33 |
Price Performance
Historical ComparisonAbout LGVN Longeveron Inc.
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.